[Ⅲ. Cancer Immunotherapies for Ovarian Cancer; Where We Stand, Perspectives and Issues]

Gan To Kagaku Ryoho. 2024 Feb;51(2):142-148.
[Article in Japanese]
No abstract available

MeSH terms

  • Female
  • Humans
  • Immunotherapy*
  • Ovarian Neoplasms* / therapy